Hamao Umezawa Memorial Award Lecture 1 'An Odyssey in the Viral Chemotherapy Field'

International Journal of Antimicrobial Agents

Volumn 18, Issue 4, 2001, Pages 309-328

  De Clercq, Erik ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antivirals; Bicyclams; Drug discovery; Interferon; Nucleosides; Nucleotides; Polyanions; Ribavirin

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; 3 DEAZAARISTEROMYCIN; 5 (2 BROMOVINYL) 2' DEOXYURIDINE; 9 (2,3 DIHYDROXYPROPYL)ADENINE; ACICLOVIR; ACYCLIC NUCLEOSIDE; ADENOSYLHOMOCYSTEINASE INHIBITOR; ANTIINFECTIVE AGENT; CYCLAM DERIVATIVE; DEOXYURIDINE DERIVATIVE; DEXTRAN SULFATE; ESTER; GUANOSINE DERIVATIVE; INOSINATE DEHYDROGENASE INHIBITOR; INTERFERON; INTERFERON INDUCING AGENT; NAPHTHALENESULFONIC ACID DERIVATIVE; NEPLANOCIN A; PHOSPHONIC ACID DERIVATIVE; POLYACRYLIC ACID; POLYACRYLIC ACID VINYL ALCOHOL SULFATE; POLYANION; POLYMETHACRYLIC ACID; POLYVINYL ALCOHOL SULFATE; POLYVINYL SULFONATE; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; SURAMIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADENOVIRUS; ANTIVIRAL ACTIVITY; CONFERENCE PAPER; CYTOMEGALOVIRUS; DNA VIRUS; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG POTENCY; DRUG RESEARCH; DRUG STRUCTURE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PAPILLOMA VIRUS; POLYOMA VIRUS; POXVIRUS; PRIORITY JOURNAL; PROPHYLAXIS; RNA VIRUS; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

ANTIVIRAL AGENTS; BROMODEOXYURIDINE; DNA VIRUSES; ENZYME INHIBITORS; HETEROCYCLIC COMPOUNDS; HUMANS; INTERFERONS; NUCLEOSIDES; POLYMERS; RNA VIRUSES;

EID: 0034752251     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(01)00411-3     Document Type: Conference Paper

References (67)

1. Towards the magic bullet. Hamao Umezawa memorial award lecture
2. Virus interference. I. The interferon
3. Interferon: A molecule for all seasons
4. Induction of circulating interferon by synthetic anionic polymers of known composition
5. Antiviral activity of polyacrylic and polymethacrylic acids. I. Mode of action in vitro
6. Antiviral activity of polyacrylic and polymethacrylic acids II. Mode of action in vivo
7. Protective effect of interferon and polyacrylic acid in newborn mice infected with a lethal dose of vesicular stomatitis virus
8. Effect of interferon, polyacrylic acid and polymethacrylic acid on tail lesions in mice infected with vaccinia virus
9. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections
10. Synthetic interferon inducers
11. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes
12. Isolation and structure of a human fibroblast interferon gene
13. Expression of the human fibroblast interferon gene in Escherichia coli
14. RNA-dependent DNA polymerase in virions of RNA tumour viruses
15. RNA-dependent DNA polymerase in virions of Rous sarcoma virus
16. Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses
17. Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III
18. Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: Clinical pharmacology and suppression of virus replication in vivo
19. Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro
20. Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation
21. Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors
22. Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities
23. (S)-9-(2,3-Dihydroxypropyl)adenine: An aliphatic nucleoside analog with broad spectrum antiviral activity
24. Antiviral and antimetabolic activities of neplanocins
25. Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5′-nor derivatives
26. Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model
27. S-adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents
28. Ribavirin: Broad-spectrum antiviral activity
29. Mechanism of action of 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent
30. Fluoroimidazoles as antiviral agents and inhibitors of polynucleotide biosynthesis
31. Antiviral activities of 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide and related compounds
32. Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections
33. The novel immunosuppressive agent Mycophenolate Mofetil markedly potentiates the antiherpes virus activities of acyclovir, ganciclovir and penciclovir in vitro and in vivo
34. E-5-(2-Bromovinyl)-2′-deoxyuridine: A potent and selective antiherpes agent
35. Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus
36. Potent and selective inhibition of varicella-zoster virus (VZV) by nucleoside analogues with an unusual bicyclic base
37. Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side-chain
38. 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group
39. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine
40. Synthesis and antiviral activity of water-soluble esters of acyclovir [9-(2-hydroxyethoxymethyl)guanine]
41. Antiviral, antimetabolic and antineoplastic activities of 2′- or 3′-amino- or azido-substituted deoxyribonucleosides
42. 3′-Azido-3′-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro
43. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides
44. Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro
45. Design and synthesis of lipophilic phosphoramidate d4T-MP prodrugs expressing high potency against HIV in cell culture: Structural determinants for in vitro activity and QSAR
46. cycloSal-Pronucleotides of 2′,3′-dideoxyadenosine and 2′,3′-dideoxy-2′,3′-didehydroadenosine: Synthesis and antiviral evaluation of a highly efficient nucleotide delivery system
47. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative
48. A novel lead for specific anti-HIV-1 agents: 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine
49. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
50. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance
51. The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection
52. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event
53. Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100
54. Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR4
55. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4
56. Inhibition of HIV infection by bicyclams, highly potent and specific CXCR4 antagonists. Minireview
57. 262 of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100
58. A novel selective broad-spectrum anti-DNA virus agent
59. Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines
60. Therapeutic potential of HPMPC as an antiviral drug
61. Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation
62. Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine
63. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]
64. A case of human orf in an immunocompromised patient, successfully treated with cidofovir cream
65. Cidofovir in the treatment of HPV-associated lesions
66. Phosphonylmethoxyethyl purine derivatives: A new class of anti-human immunodeficiency virus agents
67. Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: Potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine